ABBV vs CRAI · P/E 81, rev $16.99B vs P/E 20, rev $411.8M
AbbVie Inc (ABBV) versus CRA International Inc (CRAI) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
CRA International Inc (CRAI) is a consulting services company listed on NASDAQ.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported CRAI revenue for 2026-07-04 was $411.8M. Net income was $24.6M. CRAI currently screens at market cap $952.1M and trailing P/E 20.4.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. CRAI currently screens at market cap $952.1M and trailing P/E 20.4.
Not investment advice. Open the ABBV and CRAI stock pages for the full models.
Not investment advice.